Bioequivalence of a Metformin/Linagliptin Fixed‐Dose Combination Tablet Compared With Coadministered Single Extended‐Release Agents in Healthy Adult Subjects.
| Publicado en: | International Journal of Clinical Practice Vol. 2025; pp. 1 - 10 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
9/11/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187949167&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 187949167 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13685031 GOA jtl: International Journal of Clinical Practice issn: 13685031 maglogo: Y pubinfo: dt: 9/11/2025 vid: 2025 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 187949167 10.1155/ijcp/7111508 187949167 ppf: 1 ppct: 9 formats: tig: atl: Bioequivalence of a Metformin/Linagliptin Fixed‐Dose Combination Tablet Compared With Coadministered Single Extended‐Release Agents in Healthy Adult Subjects. aug: au: Shin, Woo-Young Saleem, Suraiya affil: Department of Family Medicine and Smart Trial Center, , Chung-Ang University Gwangmyeong Hospital, , Chung-Ang University College of Medicine, , Seoul, Republic of Korea, cau.ac.kr sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|